Metraipolis › archive › dc_2caebb375cf4

A phase 2 study of niraparib concomitant with tumor treating fields in patients with recurrent grade 4 glioma — Europe PMC PMID:42058764

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42058764
DOI: 10.1093/noajnl/vdag076
License (as archived): solo-consultazione
Archived: 2026-11-07T05:30:54.980Z
SHA-256 of the archived text: 72f6a623350b2fe8f1ded98c69dde719e4ff75992654d56d9657bc72de53f1fa
Stable URL of this page: https://metraipolis.com/documento/dc_2caebb375cf4

How to cite

A phase 2 study of niraparib concomitant with tumor treating fields in patients with recurrent grade 4 glioma — Europe PMC PMID:42058764 — Europe PMC (en), https://europepmc.org/article/MED/42058764 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2caebb375cf4 (Metraipolis archive dc_2caebb375cf4, sha256 72f6a623350b2fe8f1ded98c69dde719e4ff75992654d56d9657bc72de53f1fa)

BibTeX

@misc{dc2caebb375cf4,
  title = {A phase 2 study of niraparib concomitant with tumor treating fields in patients with recurrent grade 4 glioma — Europe PMC PMID:42058764},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42058764},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2caebb375cf4; sha256 72f6a623350b2fe8f1ded98c69dde719e4ff75992654d56d9657bc72de53f1fa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42058764. Agents can read the archived copy with the MCP tool read_document.